human retinal progenitor cells

BIOLOGICAL4 trials

Sponsors

jCyte, Inc

Conditions

Retinitis PigmentosaRetinitis Pigmentosa (RP)

Phase 1

Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa

CompletedNCT02320812

jCyte, IncRetinitis Pigmentosa (RP)

Start: 2015-06-30End: 2017-07-19Updated: 2019-03-05

Phase 2

Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa

CompletedNCT03073733

jCyte, IncRetinitis Pigmentosa

Start: 2017-03-01End: 2020-11-13Updated: 2024-06-18

Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa

CompletedNCT04604899

jCyte, IncRetinitis Pigmentosa

Start: 2020-12-01End: 2022-03-22Updated: 2024-07-16

Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

Active, not recruitingNCT06912633

jCyte, IncRetinitis Pigmentosa

Start: 2025-06-20End: 2026-12-01Updated: 2026-07-30

Related Papers

Retinal progenitor cells (jCell) for retinitis pigmentosa

Frontiers in Cellular Neuroscience2025-08-251 citations

GMP-grade human neural progenitors delivered subretinally protect vision in rat model of retinal degeneration and survive in minipigs.

2023-09-256 citations

Update on Gene Therapy Clinical Trials for Choroideremia and Potential Experimental Therapies.

2021-01-1210 citations